Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/ABD17AF5.svg?ark=w1%2F20260515%2FABD17AF5)](https://nobleid.org/work/w1/20260515/ABD17AF5)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors